DIRECT MEDICAL COSTS ASSOCIATED WITH CLINICAL AND HEALTH CHARACTERISTICS IN VISUALLY IMPAIRED INDIVIDUALS IN SINGAPORE
Author(s)
Luo N1, Wang X1, Finkelstein EA2, Lamoureux E3, Aung T4, Wong TY4, Ang M4
1National University of Singapore, Singapore, Singapore, 2Duke-NUS Graduate Medical School, Singapore, Singapore, 3Duke, Singapore, Singapore, 4Singapore National Eye Center, Singapore, Singapore
OBJECTIVES: To examine the association of direct medical costs with clinical and health characteristics in visually impaired individuals in Singapore. METHODS: We prospectively recruited 500 visually impaired individuals due to cataract, glaucoma, diabetic retinopathy (DR), or age-related macular degeneration (AMD) from Singapore National Eye Centre. In face-to-face interviews, vision function and health status of the individuals were assessed using the 14-item Visual Functioning (VF-14) and EQ-5D questionnaires, respectively. Severity of visual impairment (VI) and direct medical costs were determined using clinical and billing data, respectively, in the study center. Annual medical costs per capita were estimated and compared for individuals with different eye diseases and in different levels of VI, vision function, and health status using generalized linear models. RESULTS: The mean (standard deviation [SD)] age of participants was 71.6 (9.8) years old. The proportion of male was 47.6% and the mean (SD) presenting visual acuity was 0.49 (0.31). The annual medical costs per capita were S$6.8K. After adjusting for socio-demographics, the annual medical costs differed in individuals with different eye diseases (AMD higher than cataract by S$13.1K, glaucoma by S$9.2K, and DR by S$12.4K), VI severity (between mild/moderate and severe VI: S$8.8K), vision function (between absence and presence of problems: S$3.7K), and health status (between absence and presence of problems: S$1.3K). CONCLUSIONS: Direct medical costs are highest in AMD individuals and are associated with clinical measure and vision function in visually impaired individuals in Singapore.
Conference/Value in Health Info
2015-05, ISPOR 2015, Philadelphia, PA, USA
Value in Health, Vol. 18, No. 3 (May 2015)
Code
PHS39
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Sensory System Disorders